Interplay Between the Cytoskeleton and DNA Damage Response in Cancer Progression
Cancers · 21.04.2025 · 17 (8) · 1378
DOI: 10.3390/cancers17081378 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 21.04.2025. Verfasst von Clarissa Esmeralda Halim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Medical Research Council, SIngapore, National Medical Research Council of Singapore.
Abstract (Originalsprache)
DNA damage has emerged as a critical factor in fuelling the development and progression of cancer. DNA damage response (DDR) pathways lie at the crux of cell fate decisions following DNA damage induction, which can either trigger the repair of detrimental DNA lesions to protect cancer cells or induce the cell death machinery to eliminate damaged cells. Cytoskeletal dynamics have a critical role to play and influence the proper function of DDR pathways. Microfilaments, intermediate filaments, microtubules, and their associated proteins are well involved in the DDR. For instance, they are not only implicated in the recruitment of specific DDR molecules to the sites of DNA damage but also in the regulation of the mobility of the damaged DNA to repair sites in the periphery of the nucleus. The exquisite roles that these cytoskeletal proteins play in different DDR pathways, such as non-homologous end joining (NHEJ), homologous recombination (HR), base excision repair (BER), and nucleotide excision repair (NER), in cancer cells are extensively discussed in this review. Many cancer treatments are reliant upon inducing DNA damage in cancer cells to eliminate them; thus, it is important to shed light on factors that could affect their efficacy. Although the cytoskeleton is intricately involved in the DDR process, this has often been overlooked in cancer research and has not been exploited in developing DDR-targeting cancer therapy. Understanding the interplay between the cytoskeleton and the DDR in cancer will then provide insights into improving the development of cancer therapies that can leverage the synergistic action of DDR inhibitors and cytoskeleton-targeting agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.
- NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
- Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.
- National University Cancer Institute, National University Health System, Singapore 119074, Singapore.
ORCID-Profile: Karen Carmelina Crasta, Celestial T Yap
Förderung
- National Medical Research Council, SIngapore
- National Medical Research Council of Singapore
Zitieren
APA
Halim, C. E., Deng, S., Crasta, K. C., & Yap, C. T. (2025). Interplay Between the Cytoskeleton and DNA Damage Response in Cancer Progression. Cancers, 17(8), 1378. https://doi.org/10.3390/cancers17081378
Vancouver
Halim CE, Deng S, Crasta KC, Yap CT. Interplay Between the Cytoskeleton and DNA Damage Response in Cancer Progression. Cancers. 2025;17(8):1378. doi:10.3390/cancers17081378
BibTeX
@article{Halim2025,
author = {Halim, Clarissa Esmeralda and Deng, Shuo and Crasta, Karen Carmelina and Yap, Celestial T},
title = {Interplay Between the Cytoskeleton and DNA Damage Response in Cancer Progression},
journal = {Cancers},
year = {2025},
volume = {17},
number = {8},
pages = {1378},
doi = {10.3390/cancers17081378}
}
EUVIMED